GT BIOPHARMA, INC.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2011 | $26.0K | $-3.9M | $-3.7M |
| FY2012 | $342.0K | $-3.5M | $-5.2M |
| FY2013 | $368.0K | $-793.0K | $-501.0K |
| FY2014 | $61.0K | $-2.4M | $-23.5M |
| FY2015 | $27.0K | $-8.9M | $-21.5M |
| FY2016 | $0 | $-9.4M | $9.8M |
| FY2017 | $0 | $-135.6M | $-144.2M |
| FY2018 | — | $-250.1M | $-259.2M |
| FY2019 | $0 | $16.1M | $-38.6M |
| FY2020 | $0 | $-6.8M | $-28.3M |
| FY2021 | — | $-57.5M | $-58.0M |
| FY2022 | — | $-21.3M | $-20.9M |
| FY2023 | — | $-13.6M | $-7.6M |
| FY2024 | — | $-14.4M | $-13.2M |
| FY2025 | — | $-12.4M | $-28.4M |